Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 11 studies | 31% ± 15% | |
adipocyte | 9 studies | 29% ± 12% | |
retinal rod cell | 7 studies | 37% ± 18% | |
endothelial cell | 7 studies | 25% ± 8% | |
epithelial cell | 6 studies | 32% ± 7% | |
hepatocyte | 5 studies | 55% ± 21% | |
retinal pigment epithelial cell | 4 studies | 39% ± 11% | |
cardiac muscle cell | 4 studies | 33% ± 3% | |
macrophage | 4 studies | 21% ± 2% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 8% | |
oligodendrocyte | 4 studies | 20% ± 4% | |
retinal cone cell | 3 studies | 24% ± 4% | |
GABAergic neuron | 3 studies | 28% ± 7% | |
goblet cell | 3 studies | 24% ± 10% | |
fibroblast | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2193.76 | 1444 / 1445 | 100% | 15.78 | 183 / 183 |
liver | 100% | 8343.67 | 226 / 226 | 100% | 17.56 | 405 / 406 |
kidney | 100% | 4835.83 | 89 / 89 | 100% | 13.99 | 897 / 901 |
intestine | 100% | 3362.36 | 966 / 966 | 99% | 13.24 | 524 / 527 |
prostate | 100% | 2089.00 | 245 / 245 | 99% | 9.38 | 499 / 502 |
stomach | 100% | 2150.27 | 358 / 359 | 100% | 14.03 | 285 / 286 |
lung | 99% | 1441.77 | 574 / 578 | 100% | 8.99 | 1150 / 1155 |
brain | 98% | 1544.63 | 2593 / 2642 | 99% | 9.86 | 701 / 705 |
pancreas | 100% | 1508.85 | 327 / 328 | 98% | 7.23 | 174 / 178 |
thymus | 100% | 2107.28 | 652 / 653 | 97% | 8.01 | 585 / 605 |
skin | 100% | 2355.03 | 1807 / 1809 | 95% | 8.24 | 448 / 472 |
ovary | 100% | 2713.00 | 180 / 180 | 94% | 5.89 | 403 / 430 |
uterus | 100% | 1664.47 | 170 / 170 | 94% | 6.75 | 430 / 459 |
bladder | 100% | 2327.33 | 21 / 21 | 91% | 7.07 | 457 / 504 |
adrenal gland | 100% | 2794.16 | 258 / 258 | 83% | 4.31 | 190 / 230 |
breast | 99% | 1800.65 | 456 / 459 | 78% | 4.41 | 877 / 1118 |
blood vessel | 100% | 2447.41 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 4866.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1407.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.58 | 45 / 45 |
adipose | 100% | 2173.18 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 3748.36 | 836 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 4.99 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 91% | 6.50 | 73 / 80 |
peripheral blood | 30% | 520.42 | 276 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032099 | Biological process | negative regulation of appetite |
GO_0007584 | Biological process | response to nutrient |
GO_0008544 | Biological process | epidermis development |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_2000272 | Biological process | negative regulation of signaling receptor activity |
GO_0007507 | Biological process | heart development |
GO_0010887 | Biological process | negative regulation of cholesterol storage |
GO_0032000 | Biological process | positive regulation of fatty acid beta-oxidation |
GO_0045923 | Biological process | positive regulation of fatty acid metabolic process |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0032868 | Biological process | response to insulin |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_1900016 | Biological process | negative regulation of cytokine production involved in inflammatory response |
GO_0019217 | Biological process | regulation of fatty acid metabolic process |
GO_0035095 | Biological process | behavioral response to nicotine |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_1904189 | Biological process | positive regulation of transformation of host cell by virus |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0009267 | Biological process | cellular response to starvation |
GO_0010891 | Biological process | negative regulation of sequestering of triglyceride |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0045471 | Biological process | response to ethanol |
GO_0046321 | Biological process | positive regulation of fatty acid oxidation |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_1903427 | Biological process | negative regulation of reactive oxygen species biosynthetic process |
GO_0042157 | Biological process | lipoprotein metabolic process |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0061052 | Biological process | negative regulation of cell growth involved in cardiac muscle cell development |
GO_0042060 | Biological process | wound healing |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_0010745 | Biological process | negative regulation of macrophage derived foam cell differentiation |
GO_0045722 | Biological process | positive regulation of gluconeogenesis |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_2000191 | Biological process | regulation of fatty acid transport |
GO_0030154 | Biological process | cell differentiation |
GO_0001666 | Biological process | response to hypoxia |
GO_0006094 | Biological process | gluconeogenesis |
GO_1903944 | Biological process | negative regulation of hepatocyte apoptotic process |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0010565 | Biological process | regulation of cellular ketone metabolic process |
GO_0070166 | Biological process | enamel mineralization |
GO_0046209 | Biological process | nitric oxide metabolic process |
GO_1903038 | Biological process | negative regulation of leukocyte cell-cell adhesion |
GO_0071332 | Biological process | cellular response to fructose stimulus |
GO_2001171 | Biological process | positive regulation of ATP biosynthetic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0008289 | Molecular function | lipid binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0031435 | Molecular function | mitogen-activated protein kinase kinase kinase binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0097371 | Molecular function | MDM2/MDM4 family protein binding |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0019902 | Molecular function | phosphatase binding |
GO_0051525 | Molecular function | NFAT protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0001216 | Molecular function | DNA-binding transcription activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPARA |
Protein name | Peroxisome proliferator-activated receptor alpha Alternative protein PPARA Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1) |
Synonyms | NR1C1 SC22CB-5E3.5-002 SC22CB-5E3.5-009 SC22CB-5E3.5-003 PPAR |
Description | FUNCTION: Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as a transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2. . |
Accessions | B0QYX1 L8E859 ENST00000440343.5 ENST00000420804.5 Q86SF0 ENST00000407236.6 [Q07869-1] Q07869 B0QYX2 ENST00000415785.5 ENST00000402126.1 [Q07869-1] |